- Home
- CAPT vs CALC Comparison
CAPT vs CALC Comparison
Compare CAPT & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPT
- CALC
- Stock Information
- Founded
- CAPT 2005
- CALC 2011
- Country
- CAPT South Korea
- CALC United States
- Employees
- CAPT N/A
- CALC N/A
- Industry
- CAPT Blank Checks
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- CAPT Finance
- CALC Health Care
- Exchange
- CAPT Nasdaq
- CALC Nasdaq
- Market Cap
- CAPT 41.1M
- CALC 48.1M
- IPO Year
- CAPT N/A
- CALC N/A
- Fundamental
- Price
- CAPT $1.05
- CALC $2.85
- Analyst Decision
- CAPT
- CALC Strong Buy
- Analyst Count
- CAPT 0
- CALC 2
- Target Price
- CAPT N/A
- CALC $14.50
- AVG Volume (30 Days)
- CAPT 161.0K
- CALC 44.9K
- Earning Date
- CAPT 01-01-0001
- CALC 08-12-2025
- Dividend Yield
- CAPT N/A
- CALC N/A
- EPS Growth
- CAPT N/A
- CALC N/A
- EPS
- CAPT N/A
- CALC N/A
- Revenue
- CAPT $17,389,944.00
- CALC N/A
- Revenue This Year
- CAPT N/A
- CALC N/A
- Revenue Next Year
- CAPT N/A
- CALC N/A
- P/E Ratio
- CAPT N/A
- CALC N/A
- Revenue Growth
- CAPT 84.70
- CALC N/A
- 52 Week Low
- CAPT $0.37
- CALC $1.42
- 52 Week High
- CAPT $2.60
- CALC $5.97
- Technical
- Relative Strength Index (RSI)
- CAPT 39.31
- CALC 53.15
- Support Level
- CAPT $1.13
- CALC $2.74
- Resistance Level
- CAPT $1.30
- CALC $3.00
- Average True Range (ATR)
- CAPT 0.07
- CALC 0.24
- MACD
- CAPT -0.02
- CALC -0.03
- Stochastic Oscillator
- CAPT 10.34
- CALC 80.27
About CAPT Captivision Inc.
Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.